ZA200703704B - Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke - Google Patents
Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral strokeInfo
- Publication number
- ZA200703704B ZA200703704B ZA200703704A ZA200703704A ZA200703704B ZA 200703704 B ZA200703704 B ZA 200703704B ZA 200703704 A ZA200703704 A ZA 200703704A ZA 200703704 A ZA200703704 A ZA 200703704A ZA 200703704 B ZA200703704 B ZA 200703704B
- Authority
- ZA
- South Africa
- Prior art keywords
- plasminogen
- intravenous injection
- treating cerebral
- cerebral stroke
- neurotoxic
- Prior art date
Links
- 102000013566 Plasminogen Human genes 0.000 title 1
- 108010051456 Plasminogen Proteins 0.000 title 1
- 208000006011 Stroke Diseases 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 238000010253 intravenous injection Methods 0.000 title 1
- 231100000501 nonneurotoxic Toxicity 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2003/004608 | 2003-05-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200703704B true ZA200703704B (en) | 2008-08-27 |
Family
ID=33395696
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200509053A ZA200509053B (en) | 2003-05-02 | 2004-04-30 | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral storke |
| ZA200703704A ZA200703704B (en) | 2003-05-02 | 2004-04-30 | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200509053A ZA200509053B (en) | 2003-05-02 | 2004-04-30 | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral storke |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JP2012077090A (en) |
| CN (1) | CN1849133B (en) |
| AU (3) | AU2003227721A1 (en) |
| CY (1) | CY1114254T1 (en) |
| DK (1) | DK1622639T3 (en) |
| EA (2) | EA013837B1 (en) |
| ES (1) | ES2401782T3 (en) |
| IL (1) | IL171636A (en) |
| MY (1) | MY151447A (en) |
| PT (1) | PT1622639E (en) |
| SI (1) | SI1622639T1 (en) |
| WO (1) | WO2004096267A1 (en) |
| ZA (2) | ZA200509053B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10153601A1 (en) | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA for the treatment of stroke |
| TWI445540B (en) | 2007-04-20 | 2014-07-21 | Ajinomoto Kk | Anti-hypothermia composition |
| EP2014296A1 (en) * | 2007-07-10 | 2009-01-14 | PAION Deutschland GmbH | Novel strategies for increasing the reperfusion in obstructed blood vessel |
| AR067345A1 (en) * | 2007-07-10 | 2009-10-07 | Paion Deutschland Gmbh | USE OF THROMBOMODULIN FOR THE PREPARATION OF A THROMBOLITIC MEDICINAL PRODUCT |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE69054B1 (en) * | 1988-07-20 | 1996-08-07 | Schering Ag | Vampire bat salivary plasminogen activators |
| NL8902454A (en) * | 1989-10-03 | 1991-05-01 | Stichting Centraal Lab | MUTANTS OF THE HUMANE PLASMINOGENIC ACTIVATOR INHIBITOR 1 (PAI-1), THEIR PREPARATION AND USE, AND RECOMBINANT POLYNUCLEOTIDES INCLUDING GENETIC INFORMATION CODING FOR THESE MUTANTS. |
| WO1993005150A1 (en) * | 1991-09-05 | 1993-03-18 | Schering Aktiengesellschaft | Collagen-induced platelet aggregation inhibitor |
| DE10153601A1 (en) * | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA for the treatment of stroke |
-
2003
- 2003-05-06 WO PCT/EP2003/004729 patent/WO2004096267A1/en not_active Ceased
- 2003-05-06 AU AU2003227721A patent/AU2003227721A1/en not_active Abandoned
-
2004
- 2004-04-30 MY MYPI20041567A patent/MY151447A/en unknown
- 2004-04-30 PT PT47305164T patent/PT1622639E/en unknown
- 2004-04-30 EA EA200501733A patent/EA013837B1/en not_active IP Right Cessation
- 2004-04-30 CN CN2004800118633A patent/CN1849133B/en not_active Expired - Fee Related
- 2004-04-30 SI SI200432000T patent/SI1622639T1/en unknown
- 2004-04-30 EA EA201000501A patent/EA201000501A1/en unknown
- 2004-04-30 ES ES04730516T patent/ES2401782T3/en not_active Expired - Lifetime
- 2004-04-30 AU AU2004233601A patent/AU2004233601B2/en not_active Ceased
- 2004-04-30 ZA ZA200509053A patent/ZA200509053B/en unknown
- 2004-04-30 ZA ZA200703704A patent/ZA200703704B/en unknown
- 2004-04-30 DK DK04730516.4T patent/DK1622639T3/en active
-
2005
- 2005-10-27 IL IL171636A patent/IL171636A/en not_active IP Right Cessation
-
2010
- 2010-02-26 AU AU2010200718A patent/AU2010200718A1/en not_active Abandoned
-
2012
- 2012-01-10 JP JP2012002501A patent/JP2012077090A/en active Pending
-
2013
- 2013-03-26 CY CY20131100248T patent/CY1114254T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1092045A1 (en) | 2007-02-02 |
| CN1849133A (en) | 2006-10-18 |
| DK1622639T3 (en) | 2013-04-15 |
| AU2004233601B2 (en) | 2009-11-26 |
| AU2004233601A1 (en) | 2004-11-11 |
| ES2401782T3 (en) | 2013-04-24 |
| JP2012077090A (en) | 2012-04-19 |
| CN1849133B (en) | 2011-03-30 |
| MY151447A (en) | 2014-05-30 |
| AU2003227721A1 (en) | 2004-11-23 |
| EA013837B1 (en) | 2010-08-30 |
| EA200501733A1 (en) | 2006-06-30 |
| IL171636A (en) | 2013-07-31 |
| SI1622639T1 (en) | 2013-05-31 |
| WO2004096267A1 (en) | 2004-11-11 |
| CY1114254T1 (en) | 2016-08-31 |
| PT1622639E (en) | 2013-04-01 |
| EA201000501A1 (en) | 2010-10-29 |
| AU2010200718A1 (en) | 2010-03-18 |
| ZA200509053B (en) | 2007-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1622639T3 (en) | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke | |
| IL173439A0 (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| EP1859914A4 (en) | Molding condition setting method and method of controlling injection molding machine | |
| PL372211A1 (en) | Thiazolyl urea compounds for the treatment of cancer | |
| IL174951A0 (en) | Method for the production of amino crotonyl compounds | |
| ZA200701583B (en) | Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 | |
| AU2003295537A8 (en) | Methods of treating cerebral ischemia | |
| EP1626692A4 (en) | Compounds for the treatment of flaviviridae infections | |
| IL175014A0 (en) | Method of administering therapeutic injections | |
| HUP0402165A3 (en) | Non-neurotoxic plasminogen activating factors for treating stroke | |
| ZA200703704B (en) | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke | |
| AU2002350660A1 (en) | Non-neurotoxic plasminogen activating factors for treating stroke | |
| SI1697383T1 (en) | Process for the purification of tacrolimus | |
| AU2003296705A8 (en) | Method for controlling the production of injection molded parts | |
| AU2003213596A8 (en) | Intraspinal continuous infusion of midazolam hydrochloride for the treatment of pain | |
| HRP20030677A2 (en) | Methods of administering epothilone analogs for the treatment of cancer | |
| ZA200603153B (en) | Pyridine compounds as inhibitors of dipetidyl peptidase IV | |
| EP1663250A4 (en) | Methods for treating bladder dysfunction | |
| GB0326485D0 (en) | Resin infused article | |
| GB2419843B (en) | Process control for gas-assisted injection molding applications | |
| IL156566A0 (en) | Urokinase plasminogen activator derived octapeptide in the treatment of multiple sclerosis | |
| TW569918U (en) | Auxiliary jig for forming mold of needle injecting type label piece | |
| GB2401573B (en) | Needle assembly for gas-assisted injection moulding | |
| PL1670841T3 (en) | Method for the production of polyol mixtures | |
| TW549219U (en) | Support sliding seat for fully injecting seat of injecting forming machine |